GET73

DRUG2 trials

Sponsors

Laboratorio Farmaceutico Ct S.r.l., Medical University of South Carolina

Conditions

Alcohol Use Disorder

Phase 1

Novel mGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes

CompletedNCT04831684

Medical University of South CarolinaAlcohol Use Disorder

Start: 2021-09-15End: 2025-12-29Updated: 2026-02-05

Phase 2

Effect of GET73 on MRS Measures of Central Glutamate and GABA in Individuals With Alcohol Use Disorder

CompletedNCT03418623

Laboratorio Farmaceutico Ct S.r.l.Alcohol Use Disorder

Start: 2018-03-08End: 2020-03-13Updated: 2020-10-08